SEARCH

Potter Clarkson is delighted to announce its relocation of its London office to new premises from Monday 19 November.

Earlier this week, the Supreme Court handed down its judgment in Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan and Actavis, holding Warner-Lambert’s patent to be invalid.

Potter Clarkson is delighted to announce that the recently-published Legal 500 2019 survey once again places our trade mark team in Tier 1 and our patent practice has retained its Tier 2 position.

The latest version of the European Patent Office’s Guidelines for Examination, valid from 1 November 2018, contains, for the first time, direct guidance on the patentability of artificial intelligence and machine learning.

On 25 October 2018, the Court of Justice of the European Union (CJEU) handed down a judgment in Boston Scientific (C-527/17) concerning Supplementary Protection Certificates (SPCs) for medicinal products in the context of medical devices.
 

Following July's judgment from the Court of Justice of the EU (CJEU), Mr Justice Arnold has handed down his final decision in Teva v Gilead, finding Gilead's SPC to be invalid.